相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
Jacob Christian Lindegaard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples
Karoline Andersen et al.
CANCERS (2022)
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients
Sara Bonlokke et al.
CELLS (2022)
CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)
David Cibula et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)
Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker
Phetploy Rungkamoltip et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Targeted next generation sequencing panel for HPV genotyping in cervical cancer
J. Lippert et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2021)
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E. E. Dumbrava et al.
ESMO OPEN (2021)
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis
Kimberly Levinson et al.
GYNECOLOGIC ONCOLOGY (2021)
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
L. Cabel et al.
ESMO OPEN (2021)
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR
Miguel Alcaide et al.
SCIENTIFIC REPORTS (2020)
Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
Hakyoung Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Bhishamjit S. Chera et al.
CLINICAL CANCER RESEARCH (2019)
Liquid biopsy of HPV DNA in cervical cancer
Tak Hong Cheung et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
The Presence of Human Papillomavirus DNA Integration is Associated with Poor Clinical Results in Patients with Third-Stage Cervical Cancer
V. I. Kiseleva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)
Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology
Andriniaina Andy Nkili-Meyong et al.
SCIENTIFIC REPORTS (2019)
Plasma HPV cell-free DNA monitoring in advances HPV-associates oropharyngeal cancer
G. J. Hanna et al.
ANNALS OF ONCOLOGY (2018)
Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma
Nicole V. Anayannis et al.
PLOS ONE (2018)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
David Cibula et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Advances in liquid biopsy approaches for early detection and monitoring of cancer
Anna Babayan et al.
GENOME MEDICINE (2018)
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Luc Cabel et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring
Zhigang Kang et al.
CLINICAL CANCER RESEARCH (2017)
Predicting response to radical (chemo) radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
Jen Y. Lee et al.
BRITISH JOURNAL OF CANCER (2017)
Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
L. Cabel et al.
EJSO (2017)
Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16
Die Hong et al.
BMC CANCER (2017)
Mechanistic signatures of HPV insertions in cervical carcinomas
Allyson Holmes et al.
NPJ GENOMIC MEDICINE (2016)
Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma
Emmanuelle Jeannot et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism
Zheng Hu et al.
NATURE GENETICS (2015)
Integration of the full-length HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration
Feng Xu et al.
VIRUS GENES (2015)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES
Chetan Bettegowda et al.
NEURO-ONCOLOGY (2014)
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia
A. Gradissimo Oliveira et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line
Andrew Adey et al.
NATURE (2013)
Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients
Maura Campitelli et al.
PLOS ONE (2012)
Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression
Dipanjana Mazumder (Indra) et al.
GYNECOLOGIC ONCOLOGY (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
In vitro Progression of Human Papillomavirus 16 Episome-Associated Cervical Neoplasia Displays Fundamental Similarities to Integrant-Associated Carcinogenesis
Elizabeth Gray et al.
CANCER RESEARCH (2010)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions
Svetlana Vinokurova et al.
CANCER RESEARCH (2008)
The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma
Wei Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts
N. Hafner et al.
ONCOGENE (2008)
Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix
Katja Lindel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer
Hugo Arias-Pulido et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response
MR Pett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation
C Talora et al.
GENES & DEVELOPMENT (2002)
HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness
G Badaracco et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique
P Peitsaro et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
WA Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)